Candida albicans is the fourth most common cause of systemic nosocomial infections,
posing a significant risk in immunocompromised individuals. As the majority of systemic C …

Candida albicans remains the main etiologic agent of candidiasis, the most common fungal
infection and now the third most frequent infection in US hospitals. The scarcity of antifungal …

Candida albicans is a major cause of human infections, ranging from relatively simple to
treat skin and mucosal diseases to systemic life-threatening invasive candidiasis. Fungal …

Candida albicans dimorphism is a crucial virulence factor during invasive candidiasis
infections, which claim the lives of nearly one-half of those afflicted. It has long been …

Filamentation is an important virulence factor of the pathogenic fungus Candida albicans.
The abolition of Candida albicans hyphal formation by disrupting sterol synthesis is an …

Each year, fungi cause more than 1.5 billion infections worldwide and have a devastating
impact on human health, particularly in immunocompromised individuals or patients in …

Candida albicans is a highly drug-resistant fungus for which new treatments are urgently
needed due to the lack of clinically effective options. In this study, we evaluated the …

Aims Focusing on phytochemicals to target the virulence factors of Candida albicans is a
promising avenue for novel antifungal compounds. Given the limited prior research on …

Candida albicans is a commensal yeast that may become pathogenic and even lethal to the
host. Over the last few decades, antifungal resistance has increased, promoting screening of …

Infections triggered by pathogenic fungi cause a serious threat to the public health care
system. In particular, an increase of antifungal drug-resistant fungi has resulted in difficulty in …